Product Information
CYCLOBENZAPRINE 7.5 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.2402 per EA under NDC 72603031101. Its NADAC has been published 77 times since Mar 5, 2025.
FDA first approved this application on May 31, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5 mg/1
Manufacturer
NorthStar Rx LLCNDC
72603031101
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CYCLOBENZAPRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208170FDA Approved
5/31/2017
TE Code
AB
On Market Since
5/31/2017
Pharmacological Classes
Price Statistics
The NADAC for CYCLOBENZAPRINE 7.5 MG TABLET has been published 77 times since Mar 5, 2025, and over the history we have for it it has declined 32.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2402 per EA |
|---|---|
| All-time high | $0.4063 (May 14, 2025) |
| All-time low | $0.2402 (Aug 19, 2026) |
| 52-week high | $0.3496 |
| 52-week low | $0.2402 |
| Median price | $0.3237 |
| Average price | $0.3244 |
| Largest weekly change | +14.7% (Mar 18, 2026) |
| Weeks tracked | 77 |
| Tracking since | Mar 5, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CYCLOBENZAPRINE 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOBENZAPRINE 7.5 MG TABLET, manufactured by NorthStar Rx LLC, is $0.2402 per EA (NDC 72603031101), effective Aug 19, 2026.
How has the price of CYCLOBENZAPRINE 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CYCLOBENZAPRINE 7.5 MG TABLET has declined 32.4%. It has been tracked across 77 weekly CMS publications since Mar 5, 2025.
What are the highest and lowest recorded NADAC prices for CYCLOBENZAPRINE 7.5 MG TABLET?
Since Mar 5, 2025, the NADAC for CYCLOBENZAPRINE 7.5 MG TABLET has ranged from a low of $0.2402 (Aug 19, 2026) to a high of $0.4063 (May 14, 2025), with a median of $0.3237 per EA.
Are there cheaper alternatives to CYCLOBENZAPRINE 7.5 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CYCLOBENZAPRINE 7.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CYCLOBENZAPRINE 7.5 MG TABLET?
CYCLOBENZAPRINE 7.5 MG TABLET (NDC 72603031101) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.